Assyro AI

Orange Book product · Generic (ANDA)

LIDOCAINE HYDROCHLORIDE

LIDOCAINE HYDROCHLORIDE

Generic (ANDA)ANDA 216780TE ATRX RUBICON RESEARCH
View LIDOCAINE HYDROCHLORIDE familyOpen on FDA Orange Book

At a glance

Mar 28, 2023

Approved

Generic (ANDA)

Application

AT

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 28, 2023

    3 yr 3 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

LIDOCAINE HYDROCHLORIDE

Strength

2%

Dosage form

SOLUTION

Route

ORAL

TE code

AT

Application

ANDA 216780

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

Yes

Active-ingredient family

View full family

Generic (ANDA) of LIDOCAINE HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo